UniProt ID | NTM1A_HUMAN | |
---|---|---|
UniProt AC | Q9BV86 | |
Protein Name | N-terminal Xaa-Pro-Lys N-methyltransferase 1 | |
Gene Name | NTMT1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 223 | |
Subcellular Localization | Nucleus . Predominantly nuclear (PubMed:24090352). | |
Protein Description | Distributive alpha-N-methyltransferase that methylates the N-terminus of target proteins containing the N-terminal motif [Ala/Gly/Pro/Ser]-Pro-Lys when the initiator Met is cleaved. Specifically catalyzes mono-, di- or tri-methylation of the exposed alpha-amino group of the Ala, Gly or Ser residue in the [Ala/Gly/Ser]-Pro-Lys motif and mono- or di-methylation of Pro in the Pro-Pro-Lys motif. Some of the substrates may be primed by METTL11B-mediated monomethylation. [PubMed: 24090352 Catalyzes the trimethylation of the N-terminal Gly in CENPA (after removal of Met-1 Responsible for the N-terminal methylation of KLHL31, MYL2, MYL3, RB1, RCC1, RPL23A and SET. Required during mitosis for normal bipolar spindle formation and chromosome segregation via its action on RCC1.] | |
Protein Sequence | MTSEVIEDEKQFYSKAKTYWKQIPPTVDGMLGGYGHISSIDINSSRKFLQRFLREGPNKTGTSCALDCGAGIGRITKRLLLPLFREVDMVDITEDFLVQAKTYLGEEGKRVRNYFCCGLQDFTPEPDSYDVIWIQWVIGHLTDQHLAEFLRRCKGSLRPNGIIVIKDNMAQEGVILDDVDSSVCRDLDVVRRIICSAGLSLLAEERQENLPDEIYHVYSFALR | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Acetylation | -------MTSEVIED -------CCHHHHHH | 9.32 | 19413330 | |
2 | Acetylation | ------MTSEVIEDE ------CCHHHHHHH | 33.33 | 20068231 | |
2 | Phosphorylation | ------MTSEVIEDE ------CCHHHHHHH | 33.33 | 20068231 | |
3 | Phosphorylation | -----MTSEVIEDEK -----CCHHHHHHHH | 28.68 | 20068231 | |
10 | Sumoylation | SEVIEDEKQFYSKAK HHHHHHHHHHHHHHH | 59.01 | - | |
10 | Ubiquitination | SEVIEDEKQFYSKAK HHHHHHHHHHHHHHH | 59.01 | 21890473 | |
10 | Ubiquitination | SEVIEDEKQFYSKAK HHHHHHHHHHHHHHH | 59.01 | 21890473 | |
10 | Ubiquitination | SEVIEDEKQFYSKAK HHHHHHHHHHHHHHH | 59.01 | 21890473 | |
10 | Ubiquitination | SEVIEDEKQFYSKAK HHHHHHHHHHHHHHH | 59.01 | 21890473 | |
10 | Sumoylation | SEVIEDEKQFYSKAK HHHHHHHHHHHHHHH | 59.01 | - | |
13 | Phosphorylation | IEDEKQFYSKAKTYW HHHHHHHHHHHHHHH | 13.53 | 27642862 | |
14 | Phosphorylation | EDEKQFYSKAKTYWK HHHHHHHHHHHHHHH | 27.68 | 25693802 | |
17 | Ubiquitination | KQFYSKAKTYWKQIP HHHHHHHHHHHHHCC | 45.98 | - | |
26 | Phosphorylation | YWKQIPPTVDGMLGG HHHHCCCCCCCCCCC | 26.35 | 21406692 | |
34 | Phosphorylation | VDGMLGGYGHISSID CCCCCCCCCCCEEEE | 12.06 | 21406692 | |
38 | Phosphorylation | LGGYGHISSIDINSS CCCCCCCEEEECHHH | 18.63 | 21406692 | |
39 | Phosphorylation | GGYGHISSIDINSSR CCCCCCEEEECHHHH | 24.55 | 21406692 | |
44 | Phosphorylation | ISSIDINSSRKFLQR CEEEECHHHHHHHHH | 31.67 | 21406692 | |
45 | Phosphorylation | SSIDINSSRKFLQRF EEEECHHHHHHHHHH | 34.69 | 21406692 | |
59 | Ubiquitination | FLREGPNKTGTSCAL HHHHCCCCCCCCCHH | 52.01 | - | |
60 | Phosphorylation | LREGPNKTGTSCALD HHHCCCCCCCCCHHC | 52.94 | 20068231 | |
60 | Ubiquitination | LREGPNKTGTSCALD HHHCCCCCCCCCHHC | 52.94 | 21890473 | |
62 | Phosphorylation | EGPNKTGTSCALDCG HCCCCCCCCCHHCCC | 26.34 | 20068231 | |
63 | Phosphorylation | GPNKTGTSCALDCGA CCCCCCCCCHHCCCC | 9.95 | 20068231 | |
89 | Sulfoxidation | PLFREVDMVDITEDF HHHCCCCEEECCHHH | 3.35 | 30846556 | |
93 | Phosphorylation | EVDMVDITEDFLVQA CCCEEECCHHHHHHH | 25.66 | 22210691 | |
102 | Phosphorylation | DFLVQAKTYLGEEGK HHHHHHHHHCCCCCC | 27.30 | 28152594 | |
103 | Phosphorylation | FLVQAKTYLGEEGKR HHHHHHHHCCCCCCE | 16.41 | 28152594 | |
109 | Ubiquitination | TYLGEEGKRVRNYFC HHCCCCCCEECCEEE | 51.50 | - | |
109 (in isoform 2) | Ubiquitination | - | 51.50 | - | |
110 | Ubiquitination | YLGEEGKRVRNYFCC HCCCCCCEECCEEEC | 43.41 | 21890473 | |
169 | Sulfoxidation | IIVIKDNMAQEGVIL EEEEECCCCCCCCEE | 6.13 | 30846556 | |
223 | Methylation | HVYSFALR------- HHHHHHCC------- | 40.85 | 115483165 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of NTM1A_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of NTM1A_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of NTM1A_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
RCC1_HUMAN | RCC1 | physical | 20668449 | |
A4_HUMAN | APP | physical | 21832049 | |
PLCG1_HUMAN | PLCG1 | physical | 22939629 | |
MET13_HUMAN | METTL13 | physical | 22939629 | |
QORL1_HUMAN | CRYZL1 | physical | 22939629 | |
MK01_HUMAN | MAPK1 | physical | 22939629 | |
MK03_HUMAN | MAPK3 | physical | 22939629 | |
DDB2_HUMAN | DDB2 | physical | 24753253 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...